Volume 2

abdominal obesity predictors of deterioration of glucose tolerance and effects of lifestyle intervention aimed at reducing visceral fat in normal glucose tolerance subjects with abdominal obesity, Akita 218–224 Abstracts from the 3rd Scientific Meeting of the Asian Association for the Study of Diabetes, 22–24 July 2011, Beijing, China Supplement 1, 1–106 adipocyte adipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseases (Review Article), Kuroda 333–340 adipocytokine effect of anti-oxidants, Ricetrienol and a-tocopherol, on adipocytokine abnormalities and fatty liver in Otsuka Long-Evans Tokushima Fatty diabetic rats, Tatsumi 186–192 adiponectin determinants of intramyocellular lipid accumulation after dietary fat loading in non-obese men, Sakurai 310–317 advanced glycation end-products receptor for advanced glycation end-products-mediated inflammation and diabetic vascular complications (Editorial), Yamamoto 155–157 AGE see advanced glycation end-products aging age-dependent decline in b-cell function assessed by an oral glucose tolerance test-based disposition index, Komada 293–296 Akt high glucose impairs the proliferation and increases the apoptosis of endothelial progenitor cells by suppression of Akt, Nakamura 262–270 aldose reductase polyol pathway and diabetic nephropathy revisited: Early tubular cell changes and glomerulopathy in diabetic mice overexpressing human aldose reductase, Hashimoto 111–122 AMP kinase AMP kinase activator a-lipoic acid: A promising therapeutic agent for metabolic syndrome? (Editorial), Lee 241–242 angiotensin II type 1 receptor blockers comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients, Yoshii 490–496 angiotensin-converting enzyme 2 pathogenesis of diabetic nephropathy (Review Article), Cao 243–247 anti-oxidant effect of anti-oxidants, Ricetrienol and a-tocopherol, on adipocytokine abnormalities and fatty liver in Otsuka Long-Evans Tokushima Fatty diabetic rats, Tatsumi 186–192 apoptosis GLP-1 receptor agonist attenuates endoplasmic reticulum stressmediated b-cell damage in Akita mice, Yamane 104–110 high glucose impairs the proliferation and increases the apoptosis of endothelial progenitor cells by suppression of Akt, Nakamura 262–270 arterial stiffness acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus, Uzui 148–153 atherosclerosis efficacy of pioglitazone on glycemic control and carotid intima– media thickness in type 2 diabetes patients with inadequate insulin therapy, Yasunari 56–62 autoimmune disease genetics and pathogenesis of type 1 diabetes: prospects for prevention and intervention (Review Article), Ikegami 415–420 autonomic function association between coefficients of variation of the R-R intervals on electrocardiograms and post-challenge hyperglycemia in patients with newly diagnosed type 2 diabetes, Nakade 324–327 autophagy autophagy protects against human islet amyloid polypeptideassociated apoptosis, Morita 48–55 azelnidipine comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients, Yoshii 490–496